HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Adoptive donor immunity protects against resolved hepatitis B virus reactivation after allogeneic haematopoietic stem cell transplantation in the world's largest retrospective cohort study.

Abstract
Reactivation of hepatitis B virus (HBV) by reverse seroconversion (HBV-RS) after allogeneic haematopoietic stem cell transplantation (allo-HSCT) can occur in patients with resolved HBV infection (rHBV, defined as negative HBV surface antigen [HBsAg] and positive HBV core antibody), and may cause fatal hepatitis. To explore the risk factors, we retrospectively identified 817 consecutive patients who underwent allo-HSCT from 2005 to 2016 in this largest single centre cohort from National Taiwan Univerisity Hospital. Transplants using donors or recipients positive for HBsAg or HBV DNA were excluded, leaving 445 rHBV patients for analysis. The 3- and 5-year cumulative incidence of HBV-RS after allo-HSCT was 8·7% and 10·5%, respectively, at a median 16 months after allo-HSCT. All had concurrent HBV reactivation. HBV flares developed in 19% of HBV-RS cases, but none experienced hepatic failure. Neither did it impact non-relapse mortality or overall survival. Multivariate analysis revealed that patients with donor lacking hepatitis B surface antibody and extensive chronic graft-versus-host disease (cGVHD) have the highest risk for HBV-RS, with 5-year incidence of 24·2%. In conclusion, adoptive immunity transfer from the donor seems to have protective effects against HBV-RS, which may alter future donor selection algorithms, and combined with extensive cGVHD provides a good target for risk-adaptive HBV prophylaxis.
AuthorsJia-Hau Liu, Xiu-Wen Liao, Chien-Hung Chen, Ming Yao, Chi-Cheng Li, Chien-Ting Lin, Cheng-Hong Tsai, Wen-Chien Chou, Hsin-An Hou, Shang-Yi Huang, Shang-Ju Wu, Yao-Chang Chen, Hwei-Fang Tien, Jih-Luh Tang, Bor-Sheng Ko
JournalBritish journal of haematology (Br J Haematol) Vol. 186 Issue 1 Pg. 72-85 (07 2019) ISSN: 1365-2141 [Electronic] England
PMID30919947 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2019 British Society for Haematology and John Wiley & Sons Ltd.
Topics
  • Adaptive Immunity
  • Adolescent
  • Adult
  • Female
  • Graft vs Host Disease
  • Hematopoietic Stem Cell Transplantation (methods)
  • Hepatitis B (immunology)
  • Hepatitis B virus (physiology)
  • Humans
  • Male
  • Middle Aged
  • Retrospective Studies
  • Seroconversion
  • Tissue Donors
  • Transplantation, Homologous
  • Virus Activation (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: